Department of Urology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul.
College of Biological Science, University of California, Davis, California, USA.
Int J Surg. 2023 Mar 1;109(3):401-411. doi: 10.1097/JS9.0000000000000170.
Post-prostatectomy urinary incontinence (PPUI) is a major complication that reduces the quality of life in patients undergoing prostatectomy for benign prostatic hyperplasia and prostate cancer. However, there are currently limited guidelines on which surgical techniques are preferred after conservative treatment for PPUI. In this study, a systematic review and network meta-analysis (NMA) that can help determine the priority for the selection of surgical methods were performed.
We retrieved data from electronic literature searches of PubMed and the Cochrane Library through August 2021. We searched for randomized controlled trials studies on the surgical treatment of PPUI after surgery for benign prostatic hyperplasia or prostate cancer and included the terms artificial urethral sphincter (AUS), adjustable sling, nonadjustable sling, and injection of the bulking agent.The NMA pooled the odds ratios and 95% credible intervals (CrIs) using the number of patients achieving urinary continence, weight of pads used per day, number of pads used per day, and the International Consultation on Incontinence Questionnaire score. The therapeutic effect of each intervention on PPUI was compared and ranked using the surface under the cumulative ranking curve.
A final 11 studies, including 1116 participants, were included in our NMA. The pooled overall odds ratios of patients achieving urinary continence compared with no treatment was 3.31 (95% CrI: 0.749, 15.710) in AUS, 2.97 (95% CrI: 0.412, 16.000) in adjustable sling, 2.33 (95% CrI: 0.559, 8.290) in nonadjustable sling, and 0.26 (95% CrI: 0.025, 2.500) in injection of bulking agent. In addition, this study shows the surface under the cumulative ranking curve values of ranking probabilities for each treatment performance, which indicated that AUS ranked first in terms of continence rate, International Consultation on Incontinence Questionnaire, pad weight, and pad use count.
The results of this study suggested that only AUS had a statistically significant effect compared to the nontreatment group and the highest PPUI treatment effect ranking among other surgical treatments.
前列腺切除术后尿失禁(PPUI)是一种主要并发症,会降低接受前列腺切除术治疗良性前列腺增生和前列腺癌患者的生活质量。然而,目前对于 PPUI 经保守治疗后的首选手术技术,指南十分有限。本研究通过系统评价和网络荟萃分析(NMA)来帮助确定手术方法选择的优先级。
我们检索了 2021 年 8 月前 PubMed 和 Cochrane 图书馆电子文献的研究数据。我们检索了关于前列腺癌或良性前列腺增生术后手术治疗 PPUI 的随机对照试验研究,并使用术语人工尿道括约肌(AUS)、可调节吊带、不可调节吊带和注射膨胀剂。NMA 使用实现尿控的患者数量、每天使用的尿垫重量、每天使用的尿垫数量和国际尿失禁咨询问卷评分,对具有相同结局的试验数据进行合并,计算比值比和 95%可信区间(CrI)。使用累积排序曲线下面积比较和排名比较每种干预措施对 PPUI 的治疗效果。
最终纳入 11 项研究,共 1116 名参与者。与无治疗相比,AUS 患者实现尿控的汇总优势比为 3.31(95%CrI:0.749,15.710),可调节吊带为 2.97(95%CrI:0.412,16.000),不可调节吊带为 2.33(95%CrI:0.559,8.290),注射膨胀剂为 0.26(95%CrI:0.025,2.500)。此外,本研究还展示了每种治疗方法表现的累积排序曲线下面积值的排序概率,表明 AUS 在控尿率、国际尿失禁咨询问卷、尿垫重量和尿垫使用次数方面的排名最高。
本研究结果表明,与非治疗组相比,仅 AUS 具有统计学意义的效果,并且在其他手术治疗中具有最高的 PPUI 治疗效果排名。